Q2 2017 Holdings
Filed 2017-08-14 | 75 holdings | $23.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $9.3M | 384,145 | 39.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.3M | 73,036 | 13.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.3M | 591,128 | 13.9% |
| Cellectis S A(CLLS) | SPONSORED ADR | 15117K103 | $2.0M | 76,404 | 8.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.0M | 135,738 | 8.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.9M | 373,409 | 8.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $922.0K | 33,214 | 3.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $848.0K | 40,000 | 3.6% |
| Loxo Oncology Inc | COM | 548862101 | $24.3K | 303,621 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $5.6K | 637,700 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $5.6K | 106,770 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $5.4K | 216,119 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $4.2K | 82,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.3K | 63,484 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.0K | 38,609 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.7K | $2,250,000 | 0.0% |
| Ishares TR Nasdq Biotec(IBB) | ETF | 464287556 | $2.7K | 8,700 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $2.5K | 221,013 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.5K | 75,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.5K | 54,508 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $2.4K | 276,317 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $2.4K | 53,309 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $2.3K | 850,328 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $2.2K | 75,500 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $2.1K | 421,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $2.1K | 55,896 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.1K | 119,200 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $2.0K | 225,000 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $1.9K | $2,500,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $1.8K | 204,808 | 0.0% |
| Dermira Inc | NOTE 3.000% 5/1 | 24983LAA2 | $1.7K | $1,500,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.7K | 355,667 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $1.6K | 247,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.6K | 208,458 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $1.5K | 209,873 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.3K | 349,592 | 0.0% |
| Uniqure N V(QURE) | SHS | N90064101 | $1.3K | 203,907 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.2K | 9,400 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $1.2K | 266,500 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.2K | 443,478 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.2K | 377,695 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $1.1K | 37,938 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $973 | 784,508 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $941 | 85,947 | 0.0% |
| Scynexis Inc | COM | 811292101 | $907 | 506,900 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $840 | 8,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $828 | 980,352 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $809 | 55,809 | 0.0% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $796 | 1,372,862 | 0.0% |
| Ironwood Pharmaceuticals Inc | DBCV 2.250% 6/1 | 46333XAD0 | $767 | $573,000 | 0.0% |